The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Automated Analyzers Market Between 2026 And 2030?
The automated analyzers market has experienced substantial expansion in recent years. It is projected to increase from $5.39 billion in 2025 to $5.79 billion in 2026, progressing at a compound annual growth rate (CAGR) of 7.4%. Historically, this growth was driven by factors such as the reliance on manual and semi-automated testing methods, limited laboratory workforce efficiency, increasing clinical testing volumes, the growth of diagnostic laboratories, and a dependence on conventional analyzers.
The automated analyzers market is anticipated to experience robust expansion over the coming years. This market is projected to reach $7.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. The projected growth during this period is largely driven by continuous advancements in fully automated analyzers, the incorporation of AI and big data analytics, an increasing need for rapid diagnostic tools, the broadening scope of genomics and proteomics research, and the widespread implementation of point-of-care testing solutions. Key trends expected over the forecast period encompass the greater adoption of automated laboratory systems, a growing requirement for high-throughput sample processing, the integration of multi-functional analyzers within laboratories, significant expansion in clinical diagnostics and research applications, and improvements in the accuracy and standardization of analytical testing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp
What Influential Factors Are Boosting The Automated Analyzers Market Demand?
The increasing incidence of chronic illnesses is anticipated to drive the expansion of the automated analyzers market in the future. This surge in chronic disease prevalence is attributed to factors such as aging populations, detrimental lifestyle choices, and heightened global urbanization. Automated analyzers play a crucial role in managing chronic diseases by facilitating efficient and precise diagnostic tests, which in turn allows for the early identification, ongoing supervision, and therapeutic intervention for conditions such as diabetes, cardiovascular diseases, and kidney disorders. As an illustration, a report released by Kidney Research UK, a non-profit organization based in the UK, in June 2023 indicated that roughly 7.2 million individuals in the UK suffer from chronic kidney disease, accounting for more than 10% of the populace. Among these individuals, 3.25 million are contending with advanced forms of the illness, while another 3.9 million are in its initial phases. Projections suggest that by 2033, the total count of people impacted by chronic kidney disease will escalate to 7.61 million. Consequently, the expanding occurrence of chronic illnesses is fueling the expansion of the automated analyzers market.
What Segment Categories Are Evaluated In The Automated Analyzers Market Study?
The automated analyzers market covered in this report is segmented –
1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types
2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types
3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems
2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers
3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers
4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers
What Trends Are Driving Changes In The Automated Analyzers Market?
Companies in the automated analyzers market are concentrating on developing innovative solutions, such as automated clinical chemistry analyzers, to boost efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers are advanced instruments utilized in labs to conduct a broad spectrum of chemical tests on blood and other bodily fluids with minimal human involvement, thereby improving the efficiency and precision of diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, representing a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to boost testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.
Who Are The Firms Contributing To The Automated Analyzers Market Ecosystem?
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc
Access The Complete Automated Analyzers Market Report:
https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report
Which Region Holds The Largest Share In The Automated Analyzers Market?
North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Automated Analyzers Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp
Browse Through More Reports Similar to the Global Automated Analyzers Market 2026, By The Business Research Company
Hematology Analyzers And Reagents Market Report 2026
Blood Gas And Electrolyte Analyzers Market Report 2026
Veterinary Hematology Analyzers Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model